RenovoRx is a biotechnology business based in the US. RenovoRx shares (RNXT) are listed on the NASDAQ and all prices are listed in US Dollars. RenovoRx employs 8 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.05 |
|---|---|
| 52-week range | $0.53 - $2.35 |
| 50-day moving average | $1.14 |
| 200-day moving average | $1.22 |
| Wall St. target price | $5.63 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.60 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.0506 from 2024-09-11
| 1 week (2024-09-05) | 5.06% |
|---|---|
| 1 month (2024-08-12) | -7.84% |
| 3 months (2024-06-12) | -10.21% |
| 6 months (2024-03-12) | -37.83% |
| 1 year (2023-09-12) | -33.92% |
|---|---|
| 2 years (2022-09-12) | -61.09% |
| 3 years (2021-09-10) | 9.36 |
| 5 years (2019-09-08) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -70.08% |
| Return on equity TTM | -155.12% |
| Profit margin | 0% |
| Book value | $0.39 |
| Market Capitalization | $25.9 million |
TTM: trailing 12 months
We're not expecting RenovoRx to pay a dividend over the next 12 months.
Over the last 12 months, RenovoRx's shares have ranged in value from as little as $0.531 up to $2.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while RenovoRx's is 0.981. This would suggest that RenovoRx's shares are less volatile than average (for this exchange).
To put RenovoRx's beta into context you can compare it against those of similar companies.
RenovoRx, Inc. , a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California. .
Learn the basics of put options: what they are, how they work and a few examples.
Learn the basics of call options: what they are, how they work and examples.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
Check out the best-performing ETFs so far in 2024.
What to expect when you sign up for a Zacks Trade brokerage account.